Diapath SPA

Diapath SPA Diapath is a specialized company, completely made in Italy, that manufactures Instruments an Subject
2. Principles
3. Access mode
4. Community Rules
5.

REGULATION FOR THE USE OF SOCIAL MEDIA
(External Social Media Policy)

SUMMARY

1. Supervision of the contents and responsibility of the users
6. Post content
7. Restraint
8. Legislation on Privacy
9. Validity and updates

1. Subject
The document called "Regulations for the use of social media" governs the management and operation of the institutional pages of the company Diapath Spa, Diapath for short, on social networks, defining the methods of publication and access to the information contained therein. This document also defines the guidelines ("netiquette") for the use of social media. The same integrates the external social media policy, i.e. the information addressed to users about the purposes, types of content and behaviors allowed on the institutional pages/profiles created.


2. Principles
Diapath recognizes social networks as fundamental tools for the externalization of freedom of thought and expression as sanctioned by article 21 of the Constitution of the Italian Republic and article 10 of the European Convention for the protection of human rights and freedoms fundamental. The presence on social networks represents a necessary implementation of the traditional tools with which Diapath transmits all news and initiatives concerning the products and services offered. These innovative tools will help to improve the effectiveness and timeliness of information by facilitating customer knowledge of the products, commercial policies, company features, all in order to ensure implementation and greater dissemination on the market. The page on social networks therefore represents an institutional virtual place for exchanging information. Diapath social channels are spaces designed and created to convey information on the services provided and products marketed and to promote dialogue with customers.



3. Access Mode
Each user can access each social channel after personal access and registration to the reference platforms. It is understood that upon registering on the Facebook, Linkedin, Instagram, Youtube, Tik Tok and Wechat platforms, the user accepts all the rules and conditions contained therein. The same also remain valid for Diapath. Each user is civilly and criminally liable for infringement of Copyright-protected access and user licenses. The publication of the contents is subject to a moderation procedure in case of non-compliance with the policies indicated in the following regulation. Diapath in the event that activities that could lead to a crime are identified, will make a report to the judicial authority. Diapath employees, with the eventual technical supervision of the system administrator (external), compatibly with the structural peculiarities of each social media, ensure to:
• Manage profile authorizations;
• Make the appropriate communications to the Diapath structures;
• Log in with "username" and "password";
• Update their access profiles and any other technical requirements.

4. Community Rules
Any contribution from users, including constructive criticism, is appreciated by Diapath. Consistent with the rules of the community, the page administrators promote a dialogue based on courtesy, respect and education towards and between users. Diapath may occasionally share and relaunch content and messages of public interest and usefulness made by third parties (other entities, municipal administrations, etc.), while verifying, as far as possible, their accuracy and reliability. Diapath assumes no responsibility for any incorrect or outdated information published by third parties. Please note that the pages and accounts on social networks are not official channels for collecting reports or complaints. For these purposes it is necessary to send an email to claims@diapath.com. Comments, photos, videos and other graphic material inserted must comply with the requirements of general interest, positive criticism, respect for the privacy of people. Behaviors allowed for Facebook users:
Users who interact with the Diapath page on Facebook can:
• appreciate the contents (posts) published on the Diapath bulletin board by clicking "Like";
• comment on the contents (posts) published on the Diapath bulletin board (news, photos, videos, events and links);
• share the contents (posts) published on the Diapath bulletin board in your own wall;
• send private messages from your personal account to the Diapath page. Facebook users are not allowed to independently publish content on the bulletin board of the Diapath institutional page. Behaviors allowed for Instagram users:
Users who interact with Diapath institutional profile can:
• write, using your personal account, messages (tweets) intended for Diapath (it is not necessary to follow closely, that is, to be a Diapath "follower");
• write, using your personal account, private messages to the Diapath account (you must be a Diapath follower);
• forward ("retweet") to their followers the messages (tweets) published by Diapath with their own institutional account.

5. Supervision of the contents and responsibility of the users
Each individual user of the service must behave in a manner that respects ethics and the rules of good use of network services and is liable, civilly and criminally, in accordance with the laws in force, for the messages he sends, opinions he expresses and the contents he publishes within the social media pages. The page manager may modify, refuse to insert or remove any material that violates the rules of these Regulations. For this purpose, the most appropriate moderation rules will be used from time to time. The infringement of one of the community rules may lead to the recall via message of the user and, in the most serious cases, to the blocking and/or ban of the account from any type of future interaction with the page, with the notification sent to the managers of the platform and, if necessary, to the competent Authorities.

6. Post content
The contents published by Diapath on its official social accounts, unless otherwise indicated, are the property of Diapath and covered by copyright. They can be used by third parties only by citing the source of origin and without them being modified. They must comply with the company's code of ethics, available on the company website and with these Regulations. Furthermore, comments or contents with the following characteristics are not welcome and, in any case, subject to moderation:
• Interventions entered repeatedly;
• Comments not relevant to that particular topic;
• Offensive language or content;
• Comments or posts written to disturb the discussion or offend those who manage and moderate the social channels;
• Spam content.

7. Restraint
Moderation by Diapath within its own spaces takes place subsequently, or at a time following publication, and is aimed solely at containing, within the reasonable time and manner, of any behavior contrary to the rules of use. Diapath social spaces are reviewed, as a rule, from Monday to Friday. Diapath undertakes to read the messages and to provide, if requested, an answer. If the social channels are not the adequate tool to satisfy the request, the manager will inform about the correct procedures and the offices to contact. Diapath invites to have a polite, relevant and respectful conversation. On Diapath social channels everyone can intervene to express their free opinion, always following the good rules of education and respect for others. Any comments and posts that violate the conditions set out in this regulation will be moderated, even in advance, and promptly removed. Insults, foul language, threats or attitudes that damage the dignity of persons and the dignity of the institutions, the rights of minorities and minors and the principles of freedom will not be tolerated. All messages will be removed that:
• have content that promotes, fosters discrimination on the basis of sex, race, language, religion, sexual orientation, political opinions, age, nationality, mental or physical disability;
• encourage the conduct of illegal activities;
• contain information that may compromise the security of Diapath services and/or systems;
• have content that violates the interest of legal property or third parties;
• contain data that are in violation of the European Regulation and national legislation concerning the protection of personal data;
• contain messages or references to links to sexual content;
• have content that is offensive and disparaging to people;
• have contents contrary to the principles of the company code of ethics.

8. Legislation on Privacy
The processing of users' personal data responds to the policies in use on the platforms used (Facebook, etc.). The data that are shared by users through private messages sent directly to Diapath channels will be processed in compliance with the provisions of Regulation (EU) 679/2016, Legislative Decree 196/2003, Legislative Decree 101/2018 and the provisions of the Guarantor as compatible. Data collection is carried out in compliance with the principles of adequacy, relevance and limitation with reference to the purposes of the treatments to be carried out. Users can report copyright infringements or abuses to Diapath. The complete information on the corporate privacy policy can be downloaded from the website at www.Diapath.com



9. Validity and updates
These regulations were approved by the Board of Directors of the Company in the session of 15th Jul 2021 and will be promptly revised and updated if necessary. The same comes into force on the day 15th Jul 2021, and can be downloaded in the latest updated version from the company website.

Last week, we celebrated Christmas together with the entire Diapath team during a wonderful company dinner.It was a spec...
23/12/2025

Last week, we celebrated Christmas together with the entire Diapath team during a wonderful company dinner.

It was a special evening to celebrate our achievements, honor work anniversaries and well-deserved retirements, and share meaningful moments together.

In a refined black and gold atmosphere, we celebrated the milestones reached and the strength of our teamwork.
Thank you to everyone for the time, energy and dedication you bring every day.

We wish a festive season filled with joy and serenity to our Team, and to all our valued Clients and Partners. 🎄✨

Christmas Outfit Day at Diapath! 💝 Our teams dressed up in their funniest and most festive outfits to celebrate the holi...
18/12/2025

Christmas Outfit Day at Diapath! 💝

Our teams dressed up in their funniest and most festive outfits to celebrate the holiday spirit.

A little moment of joy reminding us how important it is to smile together, even in the lab.

Happy Holidays from all of us! May your season be full of laughter, joy, and memorable moments with the ones you care about.

New Webinar Focus ON | Optimizing Lab Workflow: PiSmart S1 Single Slide Printer | January 15th, 2026In many histology la...
15/12/2025

New Webinar Focus ON | Optimizing Lab Workflow: PiSmart S1 Single Slide Printer | January 15th, 2026

In many histology labs, even small inefficiencies can slow down the entire workflow.

That’s why understanding how to streamline daily processes, from slide identification to traceability, can make a real difference in productivity and quality.

On January 15th, 2026, we’ll explore these topics in a new webinar dedicated to practical ways of optimizing the lab efficiency.

During the session, we’ll walk through concrete examples and share best practices to help clarify what really matters when aiming for a smoother, more reliable workflow.

📅 January 15th, 2026
🔗 Registration link: https://diapathlabtalks.com/webinar/diapath-focus-on-optimizing-lab-workflow-pismart-s1/

Register now to improve your daily lab operations, reduce errors, and stay up to date on the latest solutions.

11/12/2025

A new video reference is now live | Dr. Milvia Garrido Millan, Zefiro Hood

In this testimonial, Dr. Milvia Garrido Millan from the Anatomic Pathology Department of Hospital Dos de Mayo explains how the Zefiro macroscopy hood has transformed their workflow, improving biosafety, providing a spacious and hands-free working environment, enhancing lighting, and enabling real-time high-resolution imaging for crucial tumour specimens.

A great insight into how Zefiro is bringing safety, precision, and efficiency to the lab.

A special thank you to Dr. Milvia Garrido Millan for her valuable words and to Diagnóstica Peruana SAC. for their continuous trust and collaboration.

Discover all our references here: https://references.diapath.com/

🌍 WHX LABS Dubai 2026Joining the global community of innovators at WHX LABS Dubai 2026, the dedicated WHX event fully fo...
10/12/2025

🌍 WHX LABS Dubai 2026

Joining the global community of innovators at WHX LABS Dubai 2026, the dedicated WHX event fully focused on laboratory innovation and where the future of laboratory science takes shape.

Visit our booth to meet the team and explore how our integrated solutions are advancing pathology workflows, improving efficiency across the lab, and supporting the future of precision diagnostics.

We look forward to connecting with you in Dubai and sharing what’s coming next for our group. Come visit StatLab Group at the Dubai World Trade Centre!

📍 Dubai World Trade Centre, Dubai, UAE
📅 10–13 February 2026
📌 Booth SA.F02

Si è appena concluso a Milano il congresso SIAPeC-IAP 2025 che ancora una volta ha confermato quanto automazione, digita...
09/12/2025

Si è appena concluso a Milano il congresso SIAPeC-IAP 2025 che ancora una volta ha confermato quanto automazione, digitalizzazione ed intelligenza artificiale stiano trasformando in profondità le scienze diagnostiche.

Grazie di cuore a tutti coloro che sono venuti a trovarci al nostro stand per il confronto, il coinvolgimento nella discussione e la visione delle nostre proposte di vera automazione per ottenere efficienza di processo.

Diapath vuole essere parte attiva della trasformazione digitale in atto in laboratorio con un approccio concreto e responsabile: integrare automazione, innovazione, digitalizzazione ed AI con solide basi di preanalitica, garanzia di affidabilità diagnostica e capacità di trasformare i "dati" in vero valore clinico.

Speciali ringraziamenti sono per il Dr. Giuseppe Mallel di Ibex e a Florence Francoise di Argos per averci aiutato a presentare rispettivamente la solidità scientifica degli algoritmi CE-IVDR e la vera automazione ed innovazione di Argos!

Insieme continuiamo a costruire una sanità più efficiente e incentrata sul paziente.
Grazie a tutti!

, , , ,

05/12/2025

SafeCapsule. MAKING A REAL DIFFERENCE IN DAILY CLINICAL PRACTICE

Ideal for safe and compliant transport and fixation of biopsy samples, Diapath SafeCapsule is a patented double-cap system, with pre-filled buffer and sealed formalin, ensures the safety of operators, patients, and specimens by eliminating any exposure to formaldehyde.

Listen to the real-life experience by Dra. Marina Urbano, Technical Coordinator of Anatomic Pathology at Hospital General de Cataluña.
A special thanks for her valuable feedback on SafeCapsule.

We also extend our thanks to our distributor ICSA for their continued support in bringing SafeCapsule to professionals in Spain.

Discover how SafeCapsule can enhance safety in your lab: https://references.diapath.com/

Spotlight on the Future of H&E Staining | December 10, 2025The evolution of hematoxylin-eosin (H&E) staining is accelera...
25/11/2025

Spotlight on the Future of H&E Staining | December 10, 2025

The evolution of hematoxylin-eosin (H&E) staining is accelerating, and we’re excited to bring you a dedicated webinar exploring what’s next for this essential histopathology technique.

Join us as leading experts dive into today’s most pressing challenges, while showcasing innovative solutions that can elevate diagnostic quality and strengthen pathologists’ confidence.

We’re honored to host an exceptional panel of speakers:
• Prof. Giuseppe Perrone - Director of Anatomical Pathology & Full Professor, Fondazione Policlinico Universitario Campus Bio-Medico di Roma
• Dr. Lorenzo Nibid - Anatomical Pathologist, Fondazione Policlinico Universitario Campus Bio-Medico di Roma
• Prof. Alessandro Caputo - Assistant Professor & Computational Pathologist, Università degli Studi di Salerno

Webinar Theme: From Variability to Precision: Elevating H&E with StainTabs Technology
Date: December 10, 2025 | Choose your slot: 10:00 AM - 4:00 PM CET
Why Join: Learn how StainTabs technology is reshaping reproducibility, driving standardization, and empowering routine diagnostics.

Register here: https://diapathlabtalks.com/webinar/from-variability-to-precision-elevating-he-with-staintabs-technology/

&E

Thank you, Carrefour Pathologie 2025!  What an incredible three days in Paris!As Carrefour Pathologie 2025 comes to a cl...
24/11/2025

Thank you, Carrefour Pathologie 2025! What an incredible three days in Paris!

As Carrefour Pathologie 2025 comes to a close, we want to extend a sincere thank you to everyone who stopped by our Booth, connected with our team, shared insights, and explored how next-generation pathology solutions can transform diagnostic workflows.

Over these past days, we had the pleasure of meeting pathologists, histology technicians, and laboratory leaders from across Europe. Your engagement, thoughtful conversations, and willingness to discuss real-world challenges are exactly what drive innovation at StatLab Group.

We look forward to continuing the conversation and building the next chapter of diagnostic excellence together.

Until next time, Paris. See you at the next event!

Ieri a Napoli si è concluso lil singolare evento “Nuove competenze per il cambiamento: gestire in team l'innovazione e l...
21/11/2025

Ieri a Napoli si è concluso lil singolare evento “Nuove competenze per il cambiamento: gestire in team l'innovazione e la trasformazione in anatomia patologica”.

Il messaggio è chiaro: l’innovazione in anatomia patologica non è solo digitale, è anche culturale e organizzativa.

In due giornate intense, coordinatori e tecnici di anatomia patologica hanno discusso, condiviso idee e strategie su come:
✅ Gestire l’innovazione in modo coeso
✅ Rafforzare collaborazione e comunicazione
✅ Superare conflitti e barriere al cambiamento

Soft skills + competenze tecniche = team capaci di trasformare sfide in opportunità. Questa è la chiave per rendere i laboratori veri motori di innovazione.

Un grazie speciale a:
👏 Tutti i partecipanti per la straordinaria partecipazione ed interazione da vero team!
👏 Dr. Giacomo Galletti per la guida garbata ed impeccabile delle sessioni
👏 Prof. Coppola e Prof. Micheli per la direzione scientifica
👏 GlobalStudio per l’organizzazione e la consueta professionalità.

Diapath è orgogliosa di aver contribuito a un evento che mette al centro la persona.
Per noi, innovazione significa tecnologia, ma soprattutto valorizzare le competenze umane e la collaborazione.

20/11/2025

The stage is set.
The lights are already on.

Carrefour Pathologie is underway in France, where expertise meets innovation.
These are the days of Pathology.

This is the spotlight of progress.

At Statlab group we’re proud to stand beside pathologists, supporting the science that shapes tomorrow.

👉 Visit us at Booth 40!

Indirizzo

Via Savoldini, 71
Martinengo
24057

Orario di apertura

Lunedì 08:30 - 17:30
Martedì 08:30 - 17:30
Mercoledì 08:30 - 17:30
Giovedì 08:30 - 17:30
Venerdì 08:30 - 17:30

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Diapath SPA pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Diapath SPA:

Condividi

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Diapath spa

🇬🇧 Click here for the English version

Vision

La nostra Vision è quella di diventare uno dei brand più importanti in Anatomia Patologica.

Un Brand di persone che offre innovazione, qualità ed affidabilità con un’attenzione particolare ai bisogni degli operatori di laboratorio biomedico.